Efficacy and Safety of the CVnCoV SARS-CoV-2 mRNA Vaccine Candidate: Results from Herald, a Phase 2b/3, Randomised, Observer-Blinded, Placebo-Controlled Clinical Trial in Ten Countries in Europe and Latin America-Reference-Cited by-同舟云学术

Efficacy and Safety of the CVnCoV SARS-CoV-2 mRNA Vaccine Candidate: Results from Herald, a Phase 2b/3, Randomised, Observer-Blinded, Placebo-Controlled Clinical Trial in Ten Countries in Europe and Latin America

Published:2021 Issue: Volume: Page:
ISSN:1556-5068
Container-title:SSRN Electronic Journal
language:en
Short-container-title:SSRN Journal

Author:

Kremsner Peter G.,Guerrero Rodolfo Andrés Ahuad,Arana Eunate,Aroca Martinez Gustavo Jose,Bonten Marc J.M.,Chandler Reynaldo,Corral Gonzalo,De Block Eddie Jan Louis,Ecker Lucie,Gabor Julian Justin,Garcia Lopez Carlos Alberto,Gonzales Lucy,Granados González María Angélica,Gorini Nestor,Grobusch Martin P.,Hrabar Adrian D.,Junker Helga,Kimura Alan,Lanata Claudio F.,Lehmann Clara,Leroux-Roels Isabel,Mann Philipp,Martinez-Reséndez Michel Fernando,Ochoa Theresa,Poy Carlos Alberto,Reyes Fentanes Maria Jose,Mejia Luis Maria Rivera,Ruiz Herrera Vida Veronica,Sáez-Llorens Xavier,Schönborn-Kellenberger Oliver,Schunk Mirjam,Garcia Alexandra Sierra,Vergara Itziar,Verstraeten Thomas,Vico Marisa,Oostvogels Lidia,Group HERALD Study

Publisher

Elsevier BV

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 Vaccines and Adverse Effects of SARS-CoV-2 in Recovered Patients of COVID-19: An In-depth Review;Journal of Pure and Applied Microbiology;2024-08-29

2. Advancement in the development of mRNA‐based vaccines for respiratory viruses;Immunology;2024-08-19

3. Efficacy and safety of COVID-19 vaccines;Cochrane Database of Systematic Reviews;2022-12-07

4. The Current Landscape of mRNA Vaccines Against Viruses and Cancer–A Mini Review;Frontiers in Immunology;2022-05-06

5. A Third Dose of the COVID-19 Vaccine, CVnCoV, Increased the Neutralizing Activity against the SARS-CoV-2 Wild-Type and Delta Variant;Vaccines;2022-03-25